HIV-1 diversity, drug-resistant mutations, and viral evolution among high-risk individuals in phase II HIV vaccine trial sites in southern China.

HIV-1 diversity, drug-resistant mutations, and viral evolution among high-risk individuals in phase II HIV vaccine trial sites in southern China.

HIV-1 prevalence in Guangxi, China, has been growing since 1996, when the first case was reported. Over half of HIV-1 positive patients in Guangxi Province were injecting drug users (IDUs), possibly because of the province's location near drug-trafficking routes. Since a phase II HIV vaccine tr...

Full description

Bibliographic Details
Main Authors: Haiyan Qi, Ke Zhao, Fei Xu, Xuzhao Zhang, Zhiyong Zhang, Li Yang, Chunling Li, Xu Liang, Weigui Guo, Shihai Chen, Zhihao Liu, Wenyan Zhang, Xiao-Fang Yu
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3711821?pdf=render

Internet

http://europepmc.org/articles/PMC3711821?pdf=render

Similar Items